Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients - The Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)

Circulation Journal

Volumn 74, Issue 5, 2010, Pages 938-945

  Jissho, Satoshi ^a   Shimada, Kenei ^a   Taguchi, Haruyuki ^a   Yoshida, Ken ^a   Fukuda, Shota ^a   Tanaka, Hidemasa ^a   Yoshikawa, Junichi ^a   Yoshiyama, Minoru ^b   Ishii, Masao ^c   Goto, Yoshio ^d  

^a Osaka Ekisaikai Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Yokohama Seamen's Insurance Hospital   (Japan)

^d Japan Physician's Association   (Japan)

Author keywords

Cardiovascular disease prevention; Elderly; Electrocardiography; Hypertension; Risk factors

Indexed keywords

EFONIDIPINE;

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INCIDENCE; JAPAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; R WAVE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; JAPAN; KIDNEY DISEASES; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE;

EID: 77951728164     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0722     Document Type: Article

References (28)

1. Korner PI, Jennings GL. Assessment of prevalence of left ventricular hypertrophy in hypertension. J Hypertens 1998; 16: 715-723.
2. Mancini GB, Dahlof B, Diez J. Surrogate markers for cardiovascular disease: Structural markers. Circulation 2004; 109(Suppl): IV22-IV30.
3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
4. Seki S, Tsurusaki T, Kasai T, Taniguchi I, Mochizuki S, Yoshimura M. Clinical significance of B-type natriuretic peptide in the assessment of untreated hypertension. Circ J 2008; 72: 770-777.
5. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors: The Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.
6. Kannel WB, Schatzkin A. Sudden death: Lessons from subsets in population studies. J Am Coll Cardiol 1985; 5: 141B-149B.
7. Sullivan JM, Vander Zwaag RV, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: Effect on survival. J Am Coll Cardiol 1993; 22: 508-513.
8. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: Management of hypertensive heart disease. Prog Cardiovasc Dis 2006; 48: 326-341.
9. Kahn S, Frishman WH, Weissman S, Ooi WL, Aronson M. Left ventricular hypertrophy on electrocardiogram: Prognostic implications from a 10-year cohort study of older subjects: A report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1996; 44: 524-529.
10. Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346-2351.
11. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31: 2115-2127.
12. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161-186.
13. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-1459.
14. Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: The MAVI study. J Am Coll Cardiol 2001; 38: 1829-1835.
15. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341.
16. Wachtell K, Okin PM, Olsen MH, Dahlof B, Devereux RB, Ibsen H, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: The LIFE Study. Circulation 2007; 116: 700-705.
17. Norman JE Jr, Levy D. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: Results of a correlated data base approach. J Am Coll Cardiol 1995; 26: 1022-1029.
18. Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, et al. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: The LIFE study. Losartan Intervention For Endpoint. Am J Hypertens 2002; 15: 663-671.
19. Murphy ML, Thenabadu PN, de Soyza N, Doherty JE, Meade J, Baker BJ, et al. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol 1984; 53: 1140-1147.
20. Ueshima K, Yasuno S, Oba K, Fujimoto A, Ogihara T, Saruta T, et al. Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: Subanalysis of the CASE-J trial. Circ J 2009; 73: 1080-1085.
21. Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, et al. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension 2009; 53: 28-34.
22. Blackburn H, Vasquez CL, Keys A. The aging electrocardiogram: A common aging process or latent coronary artery disease? Am J Cardiol 1967; 20: 618-627.
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
25. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
26. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51: 367-375.
27. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162: 2269-2276.
28. Marengoni A, Winblad B, Karp A, Fratiglioni L. Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health 2008; 98: 1198-1200.